Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
Crossref DOI link: https://doi.org/10.1007/s40273-016-0474-0
Published Online: 2016-12-07
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fust, Kelly
Li, Xiaoyan
Maschio, Michael
Villa, Guillermo
Parthan, Anju
Barron, Richard
Weinstein, Milton C.
Somers, Luc
Hoefkens, Caroline
Lyman, Gary H.
License valid from 2016-12-07